An immunohistochemical study of TAL-1 protein expression in leukaemias and lymphomas with a novel monoclonal antibody, 2TL 242

Journal of Pathology

Volumn 178, Issue 3, 1996, Pages 311-315

  Chetty, Runjan ^a,h   Pulford, Karen ^a   Jones, Margaret ^a   Mathieu Mahtjl, Daniele ^b   Close, Pauline ^c   Hussein, Sonay ^d   Pallesen, Gorm ^e   Ralfkiaer, Elizabeth ^f   Stein, Harald ^g   Gatter, Kevin ^a   Mason, David ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e University Institute of Pathology Arhus   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g FREIE UNIVERSITÄT BERLIN   (Germany)

^h JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

immunohistochemistry; monoclonal antibody; T acute lymphoblastic leukaemia; TAL1 gene

Indexed keywords

LEUKEMIA ANTIGEN; MONOCLONAL ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; T CELL LEUKEMIA;

ANTIBODIES, MONOCLONAL; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DNA-BINDING PROTEINS; ENDOTHELIUM; ERYTHROID PROGENITOR CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA; LEUKEMIA, T-CELL, ACUTE; LYMPHOMA; LYMPHOMA, FOLLICULAR; MEGAKARYOCYTES; MUSCLE, SMOOTH; PROTO-ONCOGENE PROTEINS; SWEAT GLANDS; TRANSCRIPTION FACTORS;

EID: 15844376074     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199603)178:3<311::AID-PATH477>3.0.CO;2-B     Document Type: Article

References (20)

1. Finger RL, Kagan J, Chnstofer G, et al. Involvement of the TCL-5 gene on human chromosome 1 in T-cell leukemia and melanoma Proc Natl Acad Sci USA 1989; 86: 5039-5043
2. Chen Q, Cheng J-T, Tsai LH, et al. The tal gene undergoes translocation in T-cell leukemia and potentially encodes a helix-loop-helix protein. E MJOJ 1990, 9: 415-424
3. Macintyre EA, Smit L, Ritz J, Kirsch IR, Strommger JL. Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor αβ lineage. Blood 1992; 80: 1511-1520
4. Aplan PD, Lombardl DP, Reaman G, et al. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia Blood 1992; 79: 1327-1333.
5. Mouthon M-A, Bernard O, Mitjavila M-T, et al. Expression of al-1 and GATA-binding proteins during hematopoiesis Blood 1993; 81: 647-655
6. McAlpme PJ. Shows TB, Boucheix C, Huebner M, Anderson WA. The 1991 catalog of mapped genes and report of the Nomenclature Committee Cytogcnet Cell Genet 1991; 58: 5-102.
7. Hatano M, Roberts CWM, Minden M, Crist WM, Korsmeyer SJ Deregulation of a Homeobox gene, HOX11, by the t(10;14) in T cell leukemia Science 1991; 253: 79-82
8. Pui C-H, Behm FG, Singh B, et al Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood 1990; 75: 174-179
9. Crist WM, Shuster JJ, Falletta J, et al. Clinical features and ourcome in childhood T-cell leukemia-lymphoma according to thymocyte differentiation: a Pediatric Oncology Group study Blood 1988; 72: 1891-1897.
10. Smith DB, Johnson KS. Single step purification of polypeptides expressed in Esctieruhia coil transferase. Gene 1988; 67: 31-40
11. Pulford KAF. Micklem K, Thomas J. Jones M, Mason DY A-72 kD B-cell associated surface glycoprotein is expressed at high levels in hairy cell leukaemia and plasma cell neoplasms clin Exp Immunol 1991, 85: 429-435
12. Pulford K, Lecointe N, Leroy-Viard K, Jones M, Mathieu-Mahul D, Mason DY. Expression of the TAL-1 proteins in human tissues Blood (in press).
13. Breit TM, Beishuizen A, Lugwig W-D, et al. Tal-1 deletions in T-cell acute lymphoblastic leukemia as a PCR target for detection of minimal residual disease. Leukemia 1993; 7: 2004-2011.
14. Bernard O, Lecointe N. Jonveaux P, et al. Two site-specific deletions and t(1,14) translocation restricted to human T-cell acute leukemias disrupt the 5' part of the tal-1 gene Oncogene 1991, 6: 1477-1488.
15. Aplan PD, Begley CG, Bertness V, et al. The SCL gene is formed from a transcriptionally complex locus. Mol Cell Biol 1990; 10: 6426-6435
16. Cheng J-T, Hsu H-L, Hwang L-Y, Baer R Products of the tal-1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues. Oncogene 1993; 8: 677-683.
17. Goldfarb AN, Goueli S, Mickelson D, Greenberg JM. T-cell acute lymphoblastic leukemia-the associated gene SCLltal codes for a 42 kD nuclear phosphoprotein. Blood 1992; 80: 2858-2866.
18. Kallianpur AR, Jordan JE, Brandt SJ. The SCL/tal-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 1994; 83: 1200-1208.
19. Chetty R, Pulford K, Jones M, et al. SCL/tal-1 expression in T-acute lymphoblastic leukaemia: an immunohistochemical and genotypic study. Hum Pathol (in press).
20. Smit L, Ritz J, Strommger JL, Macmtyre EA. Expression of the SCL/tal-1 gene is common in T-ALL in the absence of any detectable disruption of the gene Blood 1992; 80: 303A (Suppl)